Skip to main content

Dyadic Taps Agencourt to Sequence C. lucknowense Fungus

NEW YORK, Feb. 17 (GenomeWeb News) - Dyadic International has chosen Agencourt Bioscience to sequence the genome of its Chrysosporium lucknowense fungus, the company said yesterday.

 

Dyadic will use the data to maximize the utility of its Host Technology for the organism, also known as C1. The company said the Host Technology business "forms a cornerstone" of its Enzymes and Biosciences units.

 

Financial details of the agreement were not disclosed.

To date, Dyadic scientists have characterized approximately 30 C1 genes, the company said. With Agencourt's help, the firm "expect[s] to identify up to 12,000 genes" in the C1 genome, including genes for potential new protein and enzyme products.

 

Agencourt, an NHGRI-designated Large Scale Sequencing Center, will conduct all phases of the sequencing project, including construction of multiple libraries, high throughput sequencing, assembly, and finishing, Dyadic said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.